Dexamethason-ratiopharm® 4 mg Tabletten clinical trials

A Phase 1/2 Multicenter, Open-label Study to Assess the Safety, Pharmacokinetics and Efficacy of CC-92480 Monotherapy and in Combination with Dexamethasone in Subjects with Relapsed and Refractory Multiple Myeloma

This study is looking at a new drug, CC-92480, for people with multiple myeloma that has come back or not responded to previous treatments. It aims to see how safe the drug is, how it moves through the body, and how well it works, both on its own and with another medicine called dexamethasone.